The
Joint Department of Medical Imaging (JDMI) Research Office
(RO)
oversees JDMI operations and supports medical imaging research
activities.
With a multidisciplinary team of dedicated research
technologists, imaging physicists, scientists and clinicians,
JDMI RO has extensive expertise in image acquisition, image
post-processing techniques and image analysis. Other notable
services provided by JDMI RO include tissue biopsies for
clinical trial participants, tumor measurements, completion of
site surveys, and medical image anonymization with transfer to
study teams and off-site sponsors.
JDMI RO is also integral to the UHN Molecular Imaging Pipeline—a
three-phase program that facilitates the translation of new
molecular imaging techniques for detecting and diagnosing cancer
earlier and more accurately.
In line with UHN's Purpose of “Transforming lives and
communities through excellence in care, discovery & learning,”
JDMI RO is always striving to push the frontiers of innovation.
One such initiative underway is the enhancement of JDMI's tumor
measurement program through the implementation of Mint Medical
in 2022. The launch of this software tool will enable the
generation of automatic and comprehensive reports that display
all relevant data in addition to computer-assisted conformity
checks. It will streamline current process and provide an
additional layer of quality assurance. The JDMI RO is also
deeply engaged in supporting the JDMI Artificial Intelligence
(AI) Center, which focuses on leveraging the power of AI &
machine learning in digital pathology and integrating it with
diagnostic imaging. Combined, these activities are leading to
new and important opportunities to transform lives and
communities through excellence in medical imaging.
To learn more, visit the
JDMI RO website.
